Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
Hepatology International|September 24, 2022
N-terminal propeptide of type 3 collagen-based sequential algorithm can identify high-risk steatohepatitis and fibrosis in MAFLDLiang-Jie Tang, Gang Li, Mohammed Eslam, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 14, 2026
Fibrosis progression rate and comparison of paired liver biopsy versus non-invasive tests as surrogate endpoints for clinical trials in MetALD and ALDEllen Lyngbeck Jensen, Maja Thiele, Nikolaj Torp, et al.
Metabolism: Clinical and Experimental|December 27, 2021
Among simple non-invasive scores, Pro-C3 and ADAPT best exclude advanced fibrosis in Asian patients with MAFLDLiang-Jie Tang, Hong-Lei Ma, Mohammed Eslam, et al.
Biomedicines|August 26, 2022
Biomarkers of Clot Activation and Degradation and Risk of Future Major Cardiovascular Events in Acute Exacerbation of COPD: A Cohort Sub-Study in a Randomized Trial PopulationPeter Kamstrup, Jannie Marie Bülow Sand, Charlotte Suppli Ulrik, et al.
Nature Communications|January 4, 2019
The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesisHannah V Woodcock, Jessica D Eley, Delphine Guillotin, et al.
Journal of Hepatology|July 16, 2025
Molecular signatures discriminating different types of rejection in human liver transplantsBastian Engel, Ahmed Alaswad, Alejandro Campos-Murguia, et al.
Nature Communications|September 12, 2020
Author Correction: The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesisHannah V Woodcock, Jessica D Eley, Delphine Guillotin, et al.
Journal of Medical Genetics|July 25, 2014
Meta-analysis identifies loci affecting levels of the potential osteoarthritis biomarkers sCOMP and uCTX-II with genome wide significanceYolande F M Ramos, Sarah Metrustry, Nigel Arden, et al.
Journal of Hepatology|March 29, 2024
Opportunities and barriers in omics-based biomarker discovery for steatotic liver diseasesMaja Thiele, Ida Falk Villesen, Lili Niu, et al.
The Lancet. Gastroenterology & Hepatology|March 23, 2023
Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy studyYasaman Vali, Jenny Lee, Jerome Boursier, et al.
Pageof 12